NCT01373827已完成不适用
Protocol To Evaluate Patient Measurements After Ultrasonic Treatment.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 7
- 试验地点
- 1
研究概览
简要总结
Patients enrolled in this study will come from the Investigator's patient population and be ordinarily suitable for treatment using the MC1 device. The treatment they receive will be no different if they participate than if they do not. The study is only to observe the patients before, during and after their usual treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 50 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Healthy Female between 20 and 50 years of age, inclusive, on the day of enrolment.
- •Has a BMI between 20 and 30 kg/m
- •Is to be treated in the posterior thigh / saddlebag area using the MC
- •Has never been treated with the MC1 before.
- •Females who are post menopausal or using a medically acceptable form of birth control prior to study enrollment and during the course of the study. (i.e., condoms with spermicide, oral contraceptives contraceptive implants etc.)
排除标准
- •Subject is lactating, has a positive pregnancy test within 7 days of planned study procedure (for female subjects of child-bearing potential), or intends to become pregnant during the study.
- •Currently enrolled in another device or drug study that has not completed the required follow-up period, or has completed all other study-required follow-up less than 30 days before enrolment in this study.
- •Keloid scars, hypertorphic scars or a history of abnormal healing.
- •Any known bruising disorder, anticoagulative / thromboembolic condition , hemorrhagic (bleeding) status or use of anti coagulants.
- •Tissue ischemia in the area to be treated.
- •Suffering from concurrent conditions such as liver or kidney disorders, Hypertension or abnormally high blood pressure.
- •High cholesterol and/or diabetes.
- •Active collagen vascular disease (e.g. fibromyalgia, panniculitis, lupus etc.).
- •Tuberculosis.
- •Auxiliary electric organs (such as pacemakers), metal or myoelectric prosthesis.
- •Suffering from Endocrine syndromes or thyroid hyperfunction.
- •Active skin infection, any infection in the treated area within the last 30 days or skin disease in the area to be treated (e.g. eczema, psoriasis, urticaria, dermographism).
- •Bone, muscle or joint disease, dysfunction or healing in the area to be treated.
- •Malignancy in the area to be treated.
- •Laminectomy in the area to be treated.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Eligibility Screening for National Institute of Dental and Craniofacial Research StudiesFibromyalgiaNCT00001983National Institute of Dental and Craniofacial Research (NIDCR)300
进行中（未招募）
不适用
The HOPE Study: Characterizing Patients With Hepatitis B and CHepatitis B， ChronicHepatitis CNCT02995252University of Maryland, Baltimore550
已完成
不适用
Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in GreeceChronic Obstructive Pulmonary DiseaseNCT02187926AstraZeneca2,577
Enrolling By Invitation
不适用
Comparison of Vocal Biomarkers for Depression and Anxiety to Formal Clinical AssessmentsDepression/AnxietyNCT06464575Ellipsis Health540
已完成
2 期
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) SymptomsGERDAcid Reflux DiseaseHeartburnRegurgitationNCT00703534AstraZeneca478